Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3
- PMID: 30135013
- DOI: 10.1016/j.bbrc.2018.08.077
Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3
Abstract
Long non-coding RNAs (lncRNAs) are a crucial member of non-coding RNA family, and increasing evidence demonstrates that lncRNAs participate in the initiation and progression of cancers. Our study aimed to explore the role of lncRNA TTN-AS1 in cervical cancer (CC) development. In the present study, our results showed that TTN-AS1 was substantially increased in CC tissues and cell lines, high expression of TTN-AS1 was correlated with advanced FIGO stage, poor differentiation, lymph node metastasis, and poor overall survival of CC patients. Function assays showed that TTN-AS1 inhibition decreased the proliferation and invasion of CC cells both in vitro and in vivo. Mechanistically, we revealed that TTN-AS1 could positively modulate E2F3 expression via sponging miR-573 in CC cells. Together, our study revealed that lncRNA TTN-AS1 was involved in the progression of CC cells by regulation of miR-573-E2F3 axis, which offered a new insight into the treatment strategies of CC.
Keywords: Cervical cancer; E2F3; lncRNA TTN-AS1; miR-573.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Long noncoding RNA opa-interacting protein 5 antisense transcript 1 promotes proliferation and invasion through elevating integrin α6 expression by sponging miR-143-3p in cervical cancer.J Cell Biochem. 2019 Jan;120(1):907-916. doi: 10.1002/jcb.27454. Epub 2018 Sep 6. J Cell Biochem. 2019. PMID: 30188591
-
Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.J Cell Physiol. 2019 Aug;234(10):17494-17504. doi: 10.1002/jcp.28371. Epub 2019 Mar 25. J Cell Physiol. 2019. PMID: 30912129
-
LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):776-782. doi: 10.1080/21691401.2019.1577883. Artif Cells Nanomed Biotechnol. 2019. PMID: 30856345
-
TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.Biomed Pharmacother. 2021 Mar;135:111169. doi: 10.1016/j.biopha.2020.111169. Epub 2021 Feb 1. Biomed Pharmacother. 2021. PMID: 33433359 Review.
-
The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.Pathol Res Pract. 2018 Oct;214(10):1524-1531. doi: 10.1016/j.prp.2018.08.014. Epub 2018 Aug 20. Pathol Res Pract. 2018. PMID: 30173945 Review.
Cited by
-
lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4.Oncol Rep. 2020 Oct;44(4):1511-1523. doi: 10.3892/or.2020.7699. Epub 2020 Jul 20. Oncol Rep. 2020. PMID: 32945462 Free PMC article.
-
Long non-coding RNA TTN-AS1 promotes breast cancer cell migration and invasion via sponging miR-140-5p.Oncol Lett. 2020 Feb;19(2):1255-1260. doi: 10.3892/ol.2019.11222. Epub 2019 Dec 17. Oncol Lett. 2020. Retraction in: Oncol Lett. 2020 Nov;20(5):157. doi: 10.3892/ol.2020.12018. PMID: 31966055 Free PMC article. Retracted.
-
Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer.Front Mol Biosci. 2021 Jul 1;8:624951. doi: 10.3389/fmolb.2021.624951. eCollection 2021. Front Mol Biosci. 2021. PMID: 34277697 Free PMC article.
-
Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p.Mol Med Rep. 2021 Jan;23(1):45. doi: 10.3892/mmr.2020.11683. Epub 2020 Nov 12. Mol Med Rep. 2021. PMID: 33179096 Free PMC article.
-
CircularRNA_0119872 regulates the microRNA-582-3p/E2F transcription factor 3 pathway to promote the progression of malignant melanoma.Clinics (Sao Paulo). 2021 Oct 11;76:e3036. doi: 10.6061/clinics/2021/e3036. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 34644734 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical